Interestingly Prima Biomed DID NOT present at this year's at the 2nd Annual Cancer Immunotherapy Conference. ( Thursday, October 06, 2011)
whilst it did last year, 2010 ... along with Dendreon DNDN.... both did not presenti this year
One would infer that Prima has all its wheels in motion now ... and there is not immediate need to ' spruik ' the product ...
... and indeed give away the 'trade secrets ' .... it is time for Prima to stay ahead of the pack ... and play it's cards close to it's chest .....
... it is to some degree a ' race ' to get cVac to comercialisation and maximise the return in the investments .... both as a company going forward and for its institutional investors and mere mortal shareholders like us .
the link to see who is presented
http://www.regonline.com/builder/site/tab2.aspx?EventID=996528
2nd annual cancer immunotherapy conference
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.5¢ | 32.0¢ | $1.303M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29843 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 105523 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |